Latest news
Apogee Therapeutics (APGE) CMO trades stock under 10b5-1 plan - Stock TitanStock Titan · Sat, 08 Aug 2026 02:12:22 GMTApogee Therapeutics (NASDAQ:APGE) Insider Carl Dambkowski Sells 5,500 Shares - MarketBeatMarketBeat · Sat, 08 Aug 2026 01:40:52 GMTApogee Therapeutics CMO Carl Dambkowski disposes of USD 737,935 in common shares - BitgetBitget · Sat, 08 Aug 2026 00:43:41 GMTSei Investments Co. Grows Stock Holdings in Apogee Therapeutics Inc. $APGE - MarketBeatMarketBeat · Fri, 07 Aug 2026 09:03:22 GMTAbbVie Prices $10 Billion Senior Notes Offering to Support Apogee Therapeutics Acquisition - Global Legal ChronicleGlobal Legal Chronicle · Fri, 07 Aug 2026 00:00:00 GMTAbbVie Plans to raise $8 billion to finance deal with Apogee Therapeutics - AKM.RUAKM.RU · Wed, 05 Aug 2026 19:43:35 GMTBaron Capital Exits Apogee Therapeutics (APGE) Following AbbVie Buyout - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 12:17:25 GMTAbbVie Seeks at Least $8 Billion in Debt to Fund Apogee Deal - Bloomberg.comBloomberg.com · Tue, 04 Aug 2026 19:47:05 GMT